J&J teams with Microsoft for biologics

Johnson & Johnson’s IT-savvy pharma R&D group turned to Microsoft Research for help in expanding its small-molecule drug-development platform into biologics development. The attraction: the open-source library of bioinformatics functions within the Microsoft Biology Foundation, part of the Microsoft Biology Initiative.

Like other free, open-source software offerings, MBF provides programmers some prewritten functionality on which they can build, says R&D magazine. That translates into a big head start over an in-house platform development effort; programmers jumped right into developing a greater level of functionality for drug developers.

The J&J group also has distinguished itself as an early adopter of cloud computing.

– here’s the story

Read more: J&J teams with Microsoft for biologics – FierceBiotechIT


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Themed By Curio Display Cabinets